References
- Baber R, Wright J. A brief history of The International Menopause Society. Climacteric. 2017;20:85–90.
- Gardanne CPL. De La Menopause ou L’age critique des Femmes, 2nd ed. Paris: Mequignon-Marvais; 1821.
- Allen E, Doisy A. An ovarian hormone. JAMA. 1923;81:819–821.
- Butenandt A. Uber Progynon ein krystallisiertes weibliches sexualhormon. Naturwissenschaften. 1929;17:879–880.
- Wilson R. Feminine forever. London: WH Allen 1966.
- Gannon L, Stevens J. Portraits of menopause in mass media. Women Health. 1998;27:1–15.
- Rossouw J, Anderson G. Prentice R et al for the writing group for the WHI investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321–333.
- Manson J, Chlebowski R, Wallace R. The women’s health initiative hormone therapy trials: update and overview of health outcomes during the intervention and post stopping phases. JAMA. 2013;310:1353–1368.
- Langer RD. The evidence base for HRT: What can we believe. Climacteric. 2017;20:91–96.
- DeVilliers T, Hall J, Pinkerton J, et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2016;19:313–315.
- Munn C, Vaughan L, Talaulikar V, et al. Menopause knowledge and education in women under 40: results from an online survey. Women’s Health. 2022;18:1–14.